The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Pharmaceutical Lipid-Based Excipients Market By The End Of 2030?
The pharmaceutical lipid-based excipients market size has experienced significant expansion in recent years. It is anticipated to grow from $1.77 billion in 2025 to $1.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.2%. The historical increase can be attributed to the rise in poorly water-soluble drug pipelines, advancements in lipid formulation science, the expansion of pharmaceutical manufacturing, increasing use of oral delivery systems, and regulatory support for lipid excipients.
The pharmaceutical lipid-based excipients market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $2.29 billion, demonstrating a compound annual growth rate (CAGR) of 5.3%. This expansion during the projection period stems from several factors, including the proliferation of intricate drug formulations, a heightened need for improved drug absorption, the broader application of biologics and oncology medications, innovations in lipid technologies, and an escalating emphasis on patient-focused formulations. Key trends anticipated during the forecast period involve the expanded utilization of lipid excipients for drugs with low solubility, their increasing incorporation into oral and parenteral formulations, a greater call for excipients that boost bioavailability, the development of more lipid-based drug delivery systems, and a heightened interest in natural and environmentally friendly lipids.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
What Primary Drivers Are Shaping The Development Of The Pharmaceutical Lipid-Based Excipients Market?
The increasing prevalence of gene therapy is anticipated to drive the expansion of the pharmaceutical lipid-based excipients market. Gene therapy is a medical method focused on modifying or manipulating an individual’s genes to treat or prevent diseases. The rise in gene therapy is attributed to advancements in delivery systems, which facilitate the safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients support gene therapy by enabling effective delivery systems, ensuring the stability and precise transport of genetic material. They contribute to improved therapeutic outcomes by protecting nucleic acids and facilitating cellular uptake, thereby advancing the efficacy of modern treatments. For instance, in December 2024, data from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated that the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, an increase from five approvals in 2022. Therefore, the growth in gene therapy is propelling the pharmaceutical lipid-based excipients market forward.
Which Segment Classifications Shape The Pharmaceutical Lipid-Based Excipients Market?
The pharmaceutical lipid-based excipients market covered in this report is segmented –
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users
Subsegments:
1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils
2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils
3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC
4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats
5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs
6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids
7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate
8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides
9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids
How Are Trends Impacting The Pharmaceutical Lipid-Based Excipients Market?
Major companies operating in the pharmaceutical lipid-based excipients market are prioritizing investments, including strategic initiatives to establish advanced Centers of Excellence. These centers aim to drive innovation, enhance formulation capabilities, support drug delivery research, and strengthen their competitive standing in emerging therapeutic areas. As an illustration, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, opened a cutting-edge Technical Center of Excellence in Mumbai. This facility is designed to support India’s growing pharma market by providing specialized laboratories and tailored assistance for excipient innovation, with a focus on bioavailability, sustained release, and topical formulations, while simultaneously reinforcing its presence in the Asia-Pacific region. The state-of-the-art facility incorporates pharmaceutical and personal care application laboratories to foster innovation, encourage collaboration, and provide a productive work environment.
Which Companies Are Expanding Their Footprint In The Pharmaceutical Lipid-Based Excipients Market?
Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth
Read the full pharmaceutical lipid-based excipients market report here:
How Does The Pharmaceutical Lipid-Based Excipients Market Perform Across Major Global Regions?
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Lipid-Based Excipients Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2026, By The Business Research Company
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Organic Pharmaceutical Excipients Market Report 2026
Liposomal Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model